| Literature DB >> 24688895 |
N Vidal1, J P Cavaille1, F Graziani2, M Robin1, O Ouari1, S Pietri1, P Stocker1.
Abstract
Many carbonyl species from either lipid peroxidation or glycoxidation are extremely reactive and can disrupt the function of proteins and enzymes. 4-hydroxynonenal and methylglyoxal are the most abundant and toxic lipid-derived reactive carbonyl species. The presence of these toxics leads to carbonyl stress and cause a significant amount of macromolecular damages in several diseases. Much evidence indicates trapping of reactive carbonyl intermediates may be a useful strategy for inhibiting or decreasing carbonyl stress-associated pathologies. There is no rapid and convenient analytical method available for the assessment of direct carbonyl scavenging capacity, and a very limited number of carbonyl scavengers have been identified to date, their therapeutic potential being highlighted only recently. In this context, we have developed a new and rapid sensitive fluorimetric method for the assessment of reactive carbonyl scavengers without involvement glycoxidation systems. Efficacy of various thiol- and non-thiol-carbonyl scavenger pharmacophores was tested both using this screening assay adapted to 96-well microplates and in cultured cells. The scavenging effects on the formation of Advanced Glycation End-product of Bovine Serum Albumin formed with methylglyoxal, 4-hydroxynonenal and glucose-glycated as molecular models were also examined. Low molecular mass thiols with an α-amino-β-mercaptoethane structure showed the highest degree of inhibitory activity toward both α,β-unsaturated aldehydes and dicarbonyls. Cysteine and cysteamine have the best scavenging ability toward methylglyoxal. WR-1065 which is currently approved for clinical use as a protective agent against radiation and renal toxicity was identified as the best inhibitor of 4-hydroxynonenal.Entities:
Keywords: Carbonyl scavenger; Fluorescent adduct; Reactive carbonyl species; Screening assay
Mesh:
Substances:
Year: 2014 PMID: 24688895 PMCID: PMC3969608 DOI: 10.1016/j.redox.2014.01.016
Source DB: PubMed Journal: Redox Biol ISSN: 2213-2317 Impact factor: 11.799
Scavenging activity of MG and HNE in myeloma cells and screening assays.
| Compounds | ||||||
|---|---|---|---|---|---|---|
| NBDH | TRI | Myeloma cells | NBDH | CHD | Myeloma cells | |
| RCS | 0.1 mM | 0.006 mM | 1 mM | 0.1 mM | 0.1 mM | 0.1 mM |
| L-cysteine | 0.23±0.03 | 0.021±3×10−3 | 600 | 0.18±0.02 | 0.11±0.01 | 0.6 |
| Penicillamine | 0.26±0.03 | 0.01±2×10−3 | 700 | 0.85±0.05 | 0.75±0.05 | 0.88 |
| Glutathione | 2.5±0.03 | >0.6 | 2.1×103 | 0.24±0.03 | 0.27±0.02 | 0.8 |
| N-acetyl-cysteine | 4.2±0.05 | 6.2×103 | 0.48±0.04 | 0.56±0.07 | 0.64 | |
| Aminoguanidine | 0.74±0.16 | 0.13±7×10−3 | 103 | 8±0.6 | 0.42±0.05 | 1.6 |
| Cysteamine | 0.22±0.03 | 0.17±0.02 | ||||
| Homocysteine | 0.79±0.17 | 0.17±0.02 | ||||
| WR-1065 | 0.8±0.14 | 0.12±0.02 | ||||
| Pyrodoxamine | >10 | >10 | ||||
| Metformin | >10 | >1 | >5×103 | >10 | >10 | >5 |
| Captopril | 6.0±0.5 | 1.0±0.2 | ||||
| Carnosine | >10 | >10 | ||||
| β-Alanine | >10 | >10 | ||||
IC50 values expressed in mmol/l corresponding to 50% of inhibition of carbonyl derivative formation.
IC50 values expressed in mmol/l corresponding to 50% of toxicity induced at 1 mM and 100 µM for MG and HNE respectively. Each data point is the mean±SD from triplicate determinations. Each treatment is compared with control, and statistical significance between two groups is evaluated using Student׳s t test.
p>0.05 versus control in the absence of scavenger.
Fluorescence signal higher than control.
Fig. 6Inhibition of AGE-BSA formation by various compounds. BSA (50 mg/ml) was incubated at 37 °C for 24 h in 0.4 M phosphate buffer, pH 7.4 in the absence and presence of various concentrations of the compounds with (A) 5 mM methylglyoxal, (B) 5 mM 4-Hydroxynonenal, (C) 20 mM glucose. IC50 values of inhibition of AGE-BSA formation are expressed in equivalent of aminoguanidine. Each data point is the mean±SD from triplicate determinations. In addition, one-way ANOVA of the values yielded p<0.01. *p>0.05 versus controls in the absence of scavenger.
Cytotoxicity values of RCS incubated 24 h at 37 °C in mouse myeloma B X63Ag5815 and caco2 cells. Cytotoxicity is determined by measurement of intracellular ATP content using the luciferin–luciferase reaction. Percent viability relative to control is calculated for the various RCS in each cell line and used to calculated IC50 values for growth inhibition.
| Compounds | Cytotoxic concentration IC50 (µM) | |
|---|---|---|
| Lymphome B | Caco2 | |
| Acrolein | 3–6 | nd |
| Formaldehyde | 62.5–125 | 312–625 |
| Methylglyoxal | 250–500 | 625–1250 |
| 4-HNE | 5–10 | 10–15 |
| glyoxal | 625–1250 | nd |
| hexanal | >10 000 | nd |
Fig. 1Derivatization of aldehydes with fluorimetric agents. Derivatization of dicarbonyl with TRI to form 6-methylpterin (A), derivatization of monoaldehyde with CHD (B), derivatization of mono and dicarbonyl with NBD-H (C).
Fig. 2Chromatograms of derivatized mixture samples of TRI (20 µM) and MG (2 µM) after 1 h incubation at room temperature (a); after 1 h incubation in the presence of 100 µM cysteine (b); after 1 h incubation in the presence of 200 µM N-acetylcysteine (c), after 3 h incubation in the presence of 200 µM N-acetylcysteine (d).
Fig. 3(A) Normalized absorbance and fluorescence spectra of NBD-H (200 µmol/l) after reaction with MG (100 µmol/l) in 100 mM phosphate buffer pH 7.4. (B) Time-course of the appearance of the fluorescence (ex. 500 nm; em. 560 nm) at 37 °C of NBD-H (200 µM) with MG (♦) and HNE (■) at 100 µM. (C) Fluorescence response of MG (♦) and HNE (■) after 10 min incubation at 37 °C with NBD-H with increasing amounts of carbonyls (0.05–20 mM).
Fig. 4(A) Fluorescence response of MG with various amount of penicillamine according the NBD-H assay. (B) Fluorescence response of MG (♦) and HNE (■) with the incubation time of penicillamine and aminoguanidine respectively.
Fig. 5Thiol- and non-thiol pharmacophores used for structure–activity relationship studies on carbonyl scavenger.